Katsumi Miyauchi Selected Research

Katsumi Miyauchi Research Topics

Disease

84	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 03/2002
65	Acute Coronary Syndrome 01/2022 - 05/2004
42	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2004
22	Myocardial Infarction 05/2022 - 01/2007
16	Atrial Fibrillation 09/2022 - 01/2018
14	Inflammation (Inflammations) 04/2020 - 06/2004
13	Heart Failure 09/2022 - 10/2008
11	Hemorrhage 09/2022 - 08/2015
11	Chronic Renal Insufficiency 01/2022 - 09/2011
11	Diabetes Mellitus 01/2018 - 10/2006
9	Coronary Disease (Coronary Heart Disease) 09/2022 - 01/2008
9	Hypertension (High Blood Pressure) 05/2022 - 02/2008
9	Thrombosis (Thrombus) 05/2022 - 08/2010
9	Stroke (Strokes) 11/2021 - 03/2009
9	Death (Near-Death Experience) 05/2021 - 01/2006
9	Atherosclerotic Plaque (Atheroma) 05/2020 - 09/2010
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2012 - 12/2006
8	Stable Angina 10/2021 - 11/2012
8	Atherosclerosis 01/2020 - 06/2004
7	Hypercholesterolemia 01/2019 - 04/2008
6	Neoplasms (Cancer) 11/2022 - 01/2007
6	Hyperplasia 10/2010 - 03/2004
5	Pathologic Constriction (Stenosis) 08/2018 - 03/2004
5	Dyslipidemias (Dyslipidemia) 11/2016 - 01/2011
4	Hyperglycemia 01/2019 - 11/2006
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 10/2006
3	Unstable Angina 11/2021 - 01/2007
3	Peripheral Arterial Disease 11/2021 - 01/2011
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019 - 09/2009
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 08/2017
2	Pain (Aches) 01/2022 - 09/2007
2	Embolism (Embolus) 11/2021 - 01/2019
2	Intermittent Claudication 11/2021 - 07/2021
2	Left Ventricular Dysfunction 01/2019 - 06/2012
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2019 - 11/2017
2	Sleep Apnea Syndromes (Sleep Apnea) 10/2018 - 08/2018
2	Malnutrition (Nutritional Deficiencies) 11/2017 - 06/2017
2	Vascular Diseases (Vascular Disease) 09/2017 - 01/2011
2	Critical Illness (Critically Ill) 06/2017 - 06/2015

Drug/Important Bio-Agent (IBA)

43	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 06/2004
23	LipidsIBA 10/2022 - 08/2004
22	omega-Chloroacetophenone (Mace)IBA 01/2022 - 09/2010
21	oxidized low density lipoproteinIBA 07/2021 - 03/2004
16	LDL CholesterolIBA 10/2022 - 02/2008
13	pitavastatin (itavastatin)FDA Link 10/2022 - 06/2004
13	C-Reactive ProteinIBA 11/2021 - 09/2009
11	RivaroxabanIBA 09/2022 - 08/2018
11	Atorvastatin (Lipitor)FDA Link 01/2019 - 05/2004
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2021 - 01/2006
7	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2011
6	AnticoagulantsIBA 01/2022 - 01/2018
6	Lipoprotein(a)IBA 01/2022 - 02/2016
6	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020 - 02/2014
6	Triglycerides (Triacylglycerol)IBA 06/2019 - 09/2009
6	Amlodipine (Norvasc)FDA LinkGeneric 10/2012 - 10/2006
5	HDL CholesterolIBA 01/2022 - 09/2010
5	CholesterolIBA 06/2019 - 03/2009
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 09/2009
5	Hemoglobins (Hemoglobin)IBA 11/2017 - 03/2011
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2015 - 10/2006
4	Rosuvastatin Calcium (Crestor)FDA Link 01/2019 - 01/2009
4	lysophosphatidic acidIBA 01/2018 - 01/2012
4	AlbuminsIBA 09/2017 - 09/2009
4	azelnidipineIBA 01/2015 - 10/2009
4	Angiotensin Receptor AntagonistsIBA 01/2012 - 09/2009
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 01/2006
3	LDL Receptors (LDL Receptor)IBA 05/2020 - 01/2016
3	1,5-anhydroglucitolIBA 01/2019 - 10/2016
3	Eicosapentaenoic AcidIBA 01/2018 - 01/2016
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2018 - 08/2015
3	Arachidonic Acid (Vitamin F)IBA 01/2018 - 01/2016
3	Docosahexaenoic AcidsIBA 01/2018 - 01/2016
3	8,11,14-Eicosatrienoic Acid (Dihomo-gamma-Linolenic Acid)IBA 01/2018 - 08/2017
3	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 02/2014
3	Serum AlbuminIBA 11/2017 - 08/2017
3	pro-brain natriuretic peptide (1-76)IBA 08/2017 - 05/2011
3	Antihypertensive Agents (Antihypertensives)IBA 01/2015 - 10/2006
3	LDL Lipoproteins (beta Lipoproteins)IBA 07/2011 - 02/2008
2	CreatinineIBA 09/2022 - 09/2009
2	Pharmaceutical PreparationsIBA 05/2022 - 01/2012
2	DiureticsIBA 04/2022 - 05/2017
2	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 12/2016
2	Insulin (Novolin)FDA Link 01/2022 - 11/2006
2	Everolimus FDA Link 11/2021 - 10/2015
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 10/2010
2	SteroidsIBA 01/2019 - 11/2017
2	alirocumabIBA 01/2019 - 01/2018
2	CalciumIBA 01/2019 - 08/2015
2	Choline (Choline Chloride)IBA 01/2018 - 11/2012
2	LysophospholipidsIBA 01/2017 - 02/2015

Therapy/Procedure

55	Percutaneous Coronary Intervention 11/2022 - 12/2006
55	Therapeutics 10/2022 - 01/2007
16	Stents 11/2021 - 03/2004
14	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 02/2008
9	Drug-Eluting Stents 11/2021 - 08/2010
4	Secondary Prevention 06/2016 - 02/2010
3	Renal Dialysis (Hemodialysis) 01/2022 - 11/2016
3	Glycemic Control 11/2017 - 10/2006
2	Cardiac Rehabilitation 12/2018 - 01/2015
2	Catheters 07/2018 - 01/2018